一种用于治疗慢性乙型肝炎的独特单克隆抗体：并非所有抗体都是一样的。 - Suppr

Suppr

超能文献

A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.

作者信息

Sureau Camille

出版信息

Gut. 2016 Apr;65(4):546-7. doi: 10.1136/gutjnl-2015-310978. Epub 2015 Nov 26.

DOI:10.1136/gutjnl-2015-310978

PMID:26611231

Abstract

摘要

相似文献

A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.

Gut. 2016 Apr;65(4):546-7. doi: 10.1136/gutjnl-2015-310978. Epub 2015 Nov 26.

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Gut. 2016 Apr;65(4):658-71. doi: 10.1136/gutjnl-2014-308964. Epub 2015 Sep 30.

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1768-1773. doi: 10.1080/21645515.2017.1319021. Epub 2017 May 19.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Hepatology. 2006 Feb;43(2):209-20. doi: 10.1002/hep.21051.

The current status and future directions of hepatitis B antiviral drug discovery.

Expert Opin Drug Discov. 2017 Jan;12(1):5-15. doi: 10.1080/17460441.2017.1255195. Epub 2016 Nov 11.

Host factor-targeted hepatitis B virus therapies.

Intervirology. 2014;57(3-4):158-62. doi: 10.1159/000360938. Epub 2014 Jul 15.

[Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):164-6.

Latest developments in the treatment of hepatitis B.

Minerva Gastroenterol Dietol. 2016 Mar;62(1):88-102. Epub 2015 Oct 8.

Is antiviral drug-induced hepatitis B surface antigen loss durable?

Gastroenterology. 2014 Dec;147(6):1435-6. doi: 10.1053/j.gastro.2014.10.017.

Antiviral therapy for chronic hepatitis B.

Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005.

引用本文的文献

B cell dysfunction in chronic hepatitis B virus infection.

Liver Res. 2020 Sep 28;5(1):11-15. doi: 10.1016/j.livres.2020.09.004. eCollection 2021 Mar.

Monoclonal antibody applications in travel medicine.

Trop Dis Travel Med Vaccines. 2024 Jan 15;10(1):2. doi: 10.1186/s40794-023-00212-x.

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.

Gut. 2020 Feb;69(2):343-354. doi: 10.1136/gutjnl-2018-317725. Epub 2019 Mar 29.

Circulating and intrahepatic antiviral B cells are defective in hepatitis B.

J Clin Invest. 2018 Oct 1;128(10):4588-4603. doi: 10.1172/JCI121960. Epub 2018 Aug 9.

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1768-1773. doi: 10.1080/21645515.2017.1319021. Epub 2017 May 19.

Hepatitis B virus receptors and molecular drug targets.

Hepatol Int. 2016 Jul;10(4):567-73. doi: 10.1007/s12072-016-9718-5. Epub 2016 Mar 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.

Gut. 2016 Apr;65(4):546-7. doi: 10.1136/gutjnl-2015-310978. Epub 2015 Nov 26.

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Gut. 2016 Apr;65(4):658-71. doi: 10.1136/gutjnl-2014-308964. Epub 2015 Sep 30.

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1768-1773. doi: 10.1080/21645515.2017.1319021. Epub 2017 May 19.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Hepatology. 2006 Feb;43(2):209-20. doi: 10.1002/hep.21051.

The current status and future directions of hepatitis B antiviral drug discovery.

Expert Opin Drug Discov. 2017 Jan;12(1):5-15. doi: 10.1080/17460441.2017.1255195. Epub 2016 Nov 11.

Host factor-targeted hepatitis B virus therapies.

Intervirology. 2014;57(3-4):158-62. doi: 10.1159/000360938. Epub 2014 Jul 15.

[Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].

Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):164-6.

Latest developments in the treatment of hepatitis B.

Minerva Gastroenterol Dietol. 2016 Mar;62(1):88-102. Epub 2015 Oct 8.

Is antiviral drug-induced hepatitis B surface antigen loss durable?

Gastroenterology. 2014 Dec;147(6):1435-6. doi: 10.1053/j.gastro.2014.10.017.

Antiviral therapy for chronic hepatitis B.

Clin Liver Dis. 2010 Aug;14(3):425-38. doi: 10.1016/j.cld.2010.05.005.

引用本文的文献

B cell dysfunction in chronic hepatitis B virus infection.

Liver Res. 2020 Sep 28;5(1):11-15. doi: 10.1016/j.livres.2020.09.004. eCollection 2021 Mar.

Monoclonal antibody applications in travel medicine.

Trop Dis Travel Med Vaccines. 2024 Jan 15;10(1):2. doi: 10.1186/s40794-023-00212-x.

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.

Gut. 2020 Feb;69(2):343-354. doi: 10.1136/gutjnl-2018-317725. Epub 2019 Mar 29.

Circulating and intrahepatic antiviral B cells are defective in hepatitis B.

J Clin Invest. 2018 Oct 1;128(10):4588-4603. doi: 10.1172/JCI121960. Epub 2018 Aug 9.

Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1768-1773. doi: 10.1080/21645515.2017.1319021. Epub 2017 May 19.

Hepatitis B virus receptors and molecular drug targets.

Hepatol Int. 2016 Jul;10(4):567-73. doi: 10.1007/s12072-016-9718-5. Epub 2016 Mar 15.